Medicare Enrolled
Dr. David Cheng, M.D.
Urology Physician · Savannah, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cheng from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cheng?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cheng
Dr. David Cheng is an urology physician in Savannah, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Cheng performed 29,767 Medicare services across 10,090 unique beneficiaries.
Between the years covered by Open Payments, Dr. Cheng received a total of $10,716 from 47 pharmaceutical and/or device companies across 263 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cheng is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 3% volume in GA
$10,716 industry payments
Medicare Practice Summary
Medicare Utilization ↗29,767
Medicare services
Top 3% in GA for urology physician
10,090
Unique beneficiaries
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,488 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 7,380 | $18 | $39 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
6,425 | $0 | $1 |
| BCG treatment for bladder cancer | 2,650 | $2 | $6 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
1,420 | $3 | $30 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,249 | $57 | $140 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,216 | $8 | $25 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,168 | $2 | $27 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
1,073 | $5 | $30 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 1,057 | $130 | $700 |
| PSA test (prostate cancer screening) | 1,016 | $18 | $97 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
991 | $85 | $205 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
526 | $36 | $95 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
362 | $7 | $92 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
357 | $24 | $120 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
297 | $10 | $69 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
227 | $15 | $53 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
216 | $24 | $142 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
208 | $7 | $43 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
164 | $20 | $125 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
159 | $41 | $237 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
135 | $60 | $142 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
114 | $58 | $552 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
98 | $50 | $354 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
98 | $10 | $52 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
95 | $107 | $325 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
88 | $55 | $180 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
71 | $16 | $90 |
| Simple change of bladder tube | 70 | $66 | $225 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
67 | $75 | $771 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
66 | $184 | $1,287 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
63 | $62 | $245 |
| Routine 12-lead electrocardiogram (ECG) A test that records the electrical activity of the heart using at least 12 leads to produce a tracing. |
54 | $4 | $60 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
47 | $34 | $187 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
46 | $133 | $390 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
42 | $25 | $190 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
41 | $99 | $575 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
33 | $79 | $197 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
33 | $38 | $97 |
| Insertion of temporary bladder tube | 29 | $26 | $157 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
27 | $142 | $706 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
27 | $11 | $293 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
27 | $86 | $277 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
21 | $95 | $314 |
| PSA test (prostate cancer screening) A blood test that measures the level of prostate-specific antigen to screen for prostate cancer. |
21 | $19 | $92 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
20 | $90 | $1,379 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
19 | $306 | $2,052 |
| Voiding cystourethrogram An imaging procedure that uses X-rays to visualize the bladder and urethra while urine is being passed. |
18 | $148 | $400 |
| Ultrasound of scrotum An imaging test that uses sound waves to create pictures of the scrotum and its contents. It helps evaluate the testicles and surrounding structures. |
18 | $48 | $205 |
| Ultrasound of abdomen and pelvis blood flow An ultrasound exam that uses sound waves to visualize and assess blood flow through the arteries and veins in the abdomen and pelvis. |
18 | $68 | $532 |
| Radiologist review of urinary bladder image A radiologist examines and interprets images of the urinary bladder to assess its structure and function. |
17 | $30 | $199 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
16 | $426 | $5,300 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
16 | $2 | $122 |
| Surgical removal of prostate and lymph nodes This procedure involves the surgical removal of the prostate gland and surrounding lymph nodes using an endoscope. |
13 | $651 | $6,710 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
13 | $18 | $115 |
| New patient office visit, complex (60-74 min) | 13 | $141 | $377 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
12 | $554 | $3,239 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
50.3% medium
49.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,716
Total received (2018-2024)
Avg $1,531/year across 7 years
Top 22% in GA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
263
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$5,188 (48.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,902 (45.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$625 (5.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$827
2023
$1,098
2022
$673
2021
$1,012
2020
$4,322
2019
$2,001
2018
$783
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$152
Merck Sharp & Dohme LLC
$120
Sumitomo Pharma America, Inc.
$110
PFIZER INC.
$81
Endo USA, Inc.
$70
Bayer Healthcare Pharmaceuticals Inc.
$59
Novartis Pharmaceuticals Corporation
$44
Astellas Pharma US Inc
$37
Dendreon Pharmaceuticals LLC
$34
Davol Inc.
$31
Endo Pharmaceuticals Inc.
$23
Blue Earth Diagnostics Limited
$20
IMMUNITYBIO, INC.
$18
AstraZeneca Pharmaceuticals LP
$15
Innovation Technologies Inc
$13
Top 3 companies account for 46.2% of 2024 payments
All-time payments by company (2018-2024) ›
Intuitive Surgical, Inc.
$5,124
Dendreon Pharmaceuticals LLC
$803
Astellas Pharma US Inc
$523
PFIZER INC.
$519
Myriad Genetic Laboratories, Inc.
$428
Endo Pharmaceuticals Inc.
$267
AstraZeneca Pharmaceuticals LP
$246
ABBVIE INC.
$220
Myovant Sciences Inc.
$217
Merck Sharp & Dohme LLC
$210
Amgen Inc.
$191
Sumitomo Pharma America, Inc.
$183
Bayer Healthcare Pharmaceuticals Inc.
$172
AbbVie Inc.
$163
Bayer HealthCare Pharmaceuticals Inc.
$142
Janssen Biotech, Inc.
$122
Novartis Pharmaceuticals Corporation
$115
UROGEN PHARMA, INC.
$98
Coloplast Corp
$88
Blue Earth Diagnostics Limited
$79
UROVANT SCIENCES INC
$72
Janssen Scientific Affairs, LLC
$71
Endo USA, Inc.
$70
Boston Scientific Corporation
$68
Allergan, Inc.
$64
BOSTON SCIENTIFIC CORPORATION
$45
Merck Sharp & Dohme Corporation
$44
Allergan Inc.
$44
TOLMAR Pharmaceuticals, Inc.
$40
Davol Inc.
$31
MEDIVATION FIELD SOLUTIONS LLC
$27
Olympus America Inc.
$22
Ferring Pharmaceuticals Inc.
$22
Progenics Pharmaceuticals, Inc.
$20
UroGen Pharma, Inc.
$19
IMMUNITYBIO, INC.
$18
C. R. Bard, Inc. & Subsidiaries
$17
PROCEPT BioRobotics Corporation
$16
Laborie Medical Technologies Corp.
$15
AMAG Pharmaceuticals, Inc.
$14
Innovation Technologies Inc
$13
CONMED Corporation
$13
Foundation Medicine, Inc.
$12
AbbVie, Inc.
$12
Avadel Specialty Pharmaceuticals, LLC
$11
Retrophin, Inc.
$3
Travere Therapeutics, Inc.
$2
Top 3 companies account for 60.2% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · AMS · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · ARISTA AH FlexiTip · AVEED · Axumin · BOTOX · BOTOX THERAPEUTIC · Da Vinci Surgical System · EDEX · ELIGARD · Erleada · FIRMAGON · FOUNDATIONONE · GEMTESA · GENERAL KIDNEY STONE DISEASE · GREENLIGHT · INTRAROSA · IRRISEPT · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LithoVue · Lupron · MYRBETRIQ · Myrbetriq · Noctiva · Nubeqa · ORGOVYX · PLUVICTO · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Porges Coloplast · Prolaris · Prolia · REZUM · SPACEOAR VUE · SpeediCath · TITAN · TOVIAZ · Thiola · VESICARE · VISICLEAR · XGEVA · XIAFLEX · XTANDI · Xofigo · Xtandi · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (48%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
Urology physicians within 10 mi
17
Per 100K population
5.7
County median income
$69,575
Nearest hospital
CANDLER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Cheng is a mixed practice specialist, with above-average Medicare volume (top 3% in GA), with speaking/promotional industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Cheng experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Cheng performed 7,380 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cheng receive payments from pharmaceutical companies?
Yes. Dr. Cheng received a total of $10,716 from 47 companies across 263 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cheng's costs compare to other urology physicians in Savannah?
Dr. Cheng's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cheng) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Savannah
Browse urology physicians in Savannah ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in GA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in GA
Which GA urology physicians receive the most from drug and device companies.
By company
Intuitive Surgical, Inc. Payments to Doctors
See all physicians who received payments from Intuitive Surgical, Inc.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology